Research
Read how they describe their research on their University of British Columbia profile.
Latest papers
A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.
Frontiers in genetics · 2013
Single-nucleotide polymorphisms in reductase genes are not associated with response to daunorubicin-based remission induction.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2013
Single-nucleotide polymorphisms in aldo-keto and carbonyl reductase genes are not associated with acute cardiotoxicity after daunorubicin chemotherapy.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
Latest funding
- $25,000
Redefining Complex Disease: Using "Omic" Technologies to Define Biomolecular Subphenotypes of Disease Diagnosis, Development, and Therapy.
CIHR · 2011 · Nominated PI
- $440,222
Enzyme Variants as Biomarkers of Prostate Cancer and Anthracycline-based Cardiotoxicity.
CIHR · 2008 · Principal investigator
3 publications.
A discovery study of daunorubicin induced cardiotoxicity in a sample of acute myeloid leukemia patients prioritizes P450 oxidoreductase polymorphisms as a potential risk factor.
Lubieniecka JM, Graham J, Heffner D, Mottus R, Reid R, Hogge D, Grigliatti TA, Riggs WK
Single-nucleotide polymorphisms in reductase genes are not associated with response to daunorubicin-based remission induction.
Lubieniecka JM, Liu J, Graham J, Heffner D, Reid R, Hogge D, Grigliatti TA, Riggs WK
Single-nucleotide polymorphisms in aldo-keto and carbonyl reductase genes are not associated with acute cardiotoxicity after daunorubicin chemotherapy.
Lubieniecka JM, Liu J, Heffner D, Graham J, Reid R, Hogge D, Grigliatti TA, Riggs WK
Redefining Complex Disease: Using "Omic" Technologies to Define Biomolecular Subphenotypes of Disease Diagnosis, Development, and Therapy.
Principal investigators: Reid, Ronald E
Keywords: Biomarkers; Genomics; Metabolomics; Planning Meeting; Proteomics; Statistical Models; Subphenotypes; Traits; Transcriptomics; Whole Genome Sequencing
Enzyme Variants as Biomarkers of Prostate Cancer and Anthracycline-based Cardiotoxicity.
Principal investigators: Riggs, Wayne K; Grigliatti, Thomas A; Reid, Ronald E
Keywords: Androgens; Anticancer Drugs; Biomarkers; Cardiotoxicity; Genetic Polymorphisms (Snps); In Vitro Drug Metabolism; Insect/Bacterial Cells; Oxidative Stress; Prostate Cancer; Reducatase Enzymes; Ugts
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 27, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.